A functionalized polydopamine theranostic nanoprobe for efficient imaging of miRNA-21 and in vivo synergetic cancer therapy
Background: MicroRNAs (miRNAs) are emerging as vital biomarkers since their abnormal expression is associated with various disease types including cancer. Therefore, it is essential to develop a sensitive and specific platform to monitor the dynamic expression of miRNAs for early clinical diagnosis and treatment. In this study, we designed a functionalized polydopamine (PDA)-based theranostic nanoprobe for efficient detection of miR-21 and in vivo synergistic cancer therapy.
Methods: PDA was synthesized from dopamine hydrochloride and functionalized with polyethylene glycol (PEG). PDA-PEG nanoparticles were loaded with FITC-labeled hairpin DNA (hpDNA) and an anticancer drug doxorubicin (DOX). The measurement of miRNA-21 expression was reflected by the fluorescence quenching and release assay. The cellular toxicity of nanoprobe was assessed by Cell Counting Kit-8 (CCK-8) assay. Furthermore, the diagnosis and therapy effect of nanoparobe were investigated in xenograft tumor models.
Results: PDA-PEG nanoparticles showed good stability in different solutions and effectively quench the fluorescence of FITC-labeled hpDNA. The presence of miR-21 induced the dissociation of hpDNA from PDA-PEG and subsequent the recovery of fluorescence signals. Upon cellular uptake of these nanoprobes, a dose-dependent fluorescence activation and synergetic cytotoxic effect were observed due to the release of DOX and inhibition of miR-21 function. Furthermore, PDA-PEG-DOX-hpDNA nanoparticles can afford long-term monitoring of miR-21 and combined therapeutic efficacy in the nude mice bearing 4T1 tumors.
Conclusions: Our results demonstrate the capability of PDA-PEG-DOX-hpDNA as a theranostic nanoprobe for continuously tracking of miRNAs and synergetic cancer therapy.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
This is a list of supplementary files associated with this preprint. Click to download.
Posted 22 May, 2020
A functionalized polydopamine theranostic nanoprobe for efficient imaging of miRNA-21 and in vivo synergetic cancer therapy
Posted 22 May, 2020
Background: MicroRNAs (miRNAs) are emerging as vital biomarkers since their abnormal expression is associated with various disease types including cancer. Therefore, it is essential to develop a sensitive and specific platform to monitor the dynamic expression of miRNAs for early clinical diagnosis and treatment. In this study, we designed a functionalized polydopamine (PDA)-based theranostic nanoprobe for efficient detection of miR-21 and in vivo synergistic cancer therapy.
Methods: PDA was synthesized from dopamine hydrochloride and functionalized with polyethylene glycol (PEG). PDA-PEG nanoparticles were loaded with FITC-labeled hairpin DNA (hpDNA) and an anticancer drug doxorubicin (DOX). The measurement of miRNA-21 expression was reflected by the fluorescence quenching and release assay. The cellular toxicity of nanoprobe was assessed by Cell Counting Kit-8 (CCK-8) assay. Furthermore, the diagnosis and therapy effect of nanoparobe were investigated in xenograft tumor models.
Results: PDA-PEG nanoparticles showed good stability in different solutions and effectively quench the fluorescence of FITC-labeled hpDNA. The presence of miR-21 induced the dissociation of hpDNA from PDA-PEG and subsequent the recovery of fluorescence signals. Upon cellular uptake of these nanoprobes, a dose-dependent fluorescence activation and synergetic cytotoxic effect were observed due to the release of DOX and inhibition of miR-21 function. Furthermore, PDA-PEG-DOX-hpDNA nanoparticles can afford long-term monitoring of miR-21 and combined therapeutic efficacy in the nude mice bearing 4T1 tumors.
Conclusions: Our results demonstrate the capability of PDA-PEG-DOX-hpDNA as a theranostic nanoprobe for continuously tracking of miRNAs and synergetic cancer therapy.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8